周五盘中，医渡科技（02158.HK）股价大涨5.09%，引发市场关注。这一显著涨幅很可能与公司最新公布的财务管理举措有关。
据悉，医渡科技于6月5日宣布认购两笔大额财资管理产品。公司分别向高盛（Goldman Sachs）和摩根大通（JPMorgan Chase Bank）各认购了6000万美元的可赎回固定票息票据，总额高达1.2亿美元。这些产品期限最长为五年，预期年收益率分别介于4.3%-6.1%和4.25%-5%之间。
市场分析人士认为，医渡科技此举展示了公司强劲的现金储备实力和积极的财务管理策略。在当前的市场环境下，这些财资管理产品的预期收益率颇具吸引力，有望为公司带来可观的投资回报。投资者对这一财务决策反应积极，推动了公司股价的大幅上涨。这一举措不仅优化了公司的资金使用效率，还彰显了管理层对公司未来发展的信心，进一步增强了市场对医渡科技的正面预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.